揭示了针对xCT在头癌中的治疗途径
Jaewang Lee1, Jong-Lyel Roh2,3
1Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, 13496, Gyeonggi-do, Republic of Korea.
Cellular oncology (Dordrecht, Netherlands)
|October 3, 2024
概括
囊/谷氨酸抗载体 (xCT) 驱动头癌 (HNC) 的进展和治疗耐药性. 针对xCT提供了一个有希望的策略来改善HNC的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- 头癌 (HNC) 是一个重大的全球健康挑战.
- 目前对HNC的治疗策略需要创新,以改善患者的治疗结果.
- 囊/谷氨酸抗载体 (xCT) 越来越多地被认为是癌症进展中的作用.
研究的目的:
- 审查xCT在头癌 (HNC) 进展中的多方面的作用.
- 阐明xCT对HNC的贡献机制,包括氧化还原失衡,铁灭和治疗耐药性.
- 评估在HNC中准xCT的治疗潜力.
主要方法:
- 关于在HNC中研究xCT的综合文献综述.
- 对xCT对瘤生物学的贡献及其对治疗耐药性的影响的分析.
- 检查当前和新兴的xCT向疗法和治疗方式.
主要成果:
- xCT失调显著影响HNC瘤生物学.
- xCT通过包括氧化还原失衡和铁灭诱导在内的机制促进癌症的进展.
- xCT活性与抗常规HNC治疗的耐药性有关.
- 新兴的xCT抑制剂显示出增强HNC治疗的潜力.
结论:
- xCT是HNC进展和治疗耐药性的关键调解者.
- 向xCT代表了改善HNC治疗结果的有希望的治疗策略.
- 进一步的研究和xCT向治疗的临床应用对于HNC管理是有必要的.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
07:44Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
134
相关概念视频
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
